L. Magro

发表

Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse.

I. Yakoub-Agha, A. Duhamel, J. Jouet, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diverting Enterostomy Improves Overall Survival of Patients With Severe Steroid-refractory Gastrointestinal Acute Graft-Versus-Host Disease

S. Truant, I. Yakoub-Agha, A. Duhamel, 2021, Annals of surgery.

Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation

B. Quesnel, I. Yakoub-Agha, A. Duhamel, 2022, Annals of Hematology.

Successful treatment with fingolimod of graft-versus-host disease of the central nervous system.

P. Vermersch, I. Yakoub-Agha, V. Coiteux, 2018, Blood advances.

Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse

I. Yakoub-Agha, J. Jouet, V. Coiteux, 2010, Bone Marrow Transplantation.

Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study.

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2017, Blood.

Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.

I. Yakoub-Agha, S. Depil, J. Jouet, 2007, Experimental hematology.

Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

I. Yakoub-Agha, D. Blaise, M. Mohty, 2015, Bone Marrow Transplantation.

Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML

B. Quesnel, I. Yakoub-Agha, A. Duhamel, 2017, Bone Marrow Transplantation.

Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy

J. Tamburini, X. Leleu, T. Facon, 2018, Leukemia & lymphoma.

Impact of Defibrotide in the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

I. Yakoub-Agha, N. Simon, P. Odou, 2022, The Annals of Pharmacotherapy.

Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease.

P. Chevallier, I. Yakoub-Agha, M. Mohty, 2009, Blood.

Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

P. Chevallier, I. Yakoub-Agha, M. Mohty, 2016 .

Long-term follow up of invasive aspergillosis in allogeneic stem cell transplantation recipients and leukemia patients: Differences in risk factors and outcomes.

B. Quesnel, I. Yakoub-Agha, C. Berthon, 2017, Current research in translational medicine.

Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy.

J. Bonneterre, T. Facon, B. Cortet, 2008, Joint, bone, spine : revue du rhumatisme.

Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TC

M. Robin, I. Yakoub-Agha, F. Suarez, 2017, Bone Marrow Transplantation.

[National patient follow-up care logbook: Guidelines by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

I. Yakoub-Agha, N. Chevallier, L. Magro, 2016, Bulletin du cancer.

Severe pulmonary toxoplasmosis after allo-SCT in two patients: from Toxoplasma genotyping to clinical management

I. Yakoub-Agha, L. Delhaes, E. Dei‐Cas, 2010, Bone Marrow Transplantation.

Severe Adenovirus Pneumonia Followed by Bacterial Septicaemia: Relevance of Co-Infections in Allogeneic Hematopoietic Stem Cell Transplantation.

I. Yakoub-Agha, A. Heim, D. Hober, 2016, Infectious disorders drug targets.

Bone marrow graft as a source of allogeneic hematopoietic stem cells in patients undergoing a reduced intensity conditioning regimen

I. Yakoub-Agha, A. Duhamel, V. Coiteux, 2014, Bone Marrow Transplantation.

[Vaccination post hematopoietic stem cell transplantation: which vaccines and when and, how to vaccinate? An SFGM-TC report].

I. Yakoub-Agha, O. Reman, F. Suarez, 2013, Pathologie-biologie.

The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients

I. Yakoub-Agha, K. Faure, E. Alidjinou, 2022, Blood advances.

Chronic graft-versus-host disease revealed by lichenoid vulvar lesions successfully treated with thalidomide.

J. Jouet, B. Catteau, D. Staumont-Sallé, 2003, Acta dermato-venereologica.

[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)].

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2014, Pathologie-biologie.

[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1)].

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2014, Pathologie-biologie.

Haemophagocytic lymphohistiocytosis following allogeneic hematopoietic cell transplantation from mismatched unrelated donors associated with low CD34 and CD3 cell counts in the graft

I. Yakoub-Agha, V. Coiteux, C. Ballot, 2022, Bone Marrow Transplantation.

The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.

I. Yakoub-Agha, V. Coiteux, J. Gauthier, 2020, Current research in translational medicine.

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2019, Bone Marrow Transplantation.

Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC.

M. Robin, P. Chevallier, G. Guillerm, 2023, Transplantation and cellular therapy.

Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD

I. Yakoub-Agha, J. Jouet, B. Catteau, 2008, Bone Marrow Transplantation.

A case of subacute bowel obstruction revealing slowly-evolutive gastro-intestinal mucormycosis following allogeneic hematopoietic cell transplantation.

I. Yakoub-Agha, S. Alfandari, E. Fréalle, 2022, Journal de mycologie medicale.

Successful treatment with fingolimod of graft-versus-host disease of the central nervous system.

P. Vermersch, I. Yakoub-Agha, V. Coiteux, 2018, Blood advances.

Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®) in a Patient with Graft-versus-host Disease

I. Yakoub-Agha, J. Jouet, F. Kuhnowski, 2006, Drugs.

Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

P. Chevallier, I. Yakoub-Agha, G. Guillerm, 2023, Bone Marrow Transplantation.

Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease

I. Yakoub-Agha, G. Damaj, J. Labreuche, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[Transfer of skills: implementing post-transplant follow-up care status for transplant nurses: a report by the SFGM-TC].

I. Yakoub-Agha, J. Cornillon, R. Peffault de Latour, 2014, Pathologie-biologie.

Medication non‐adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

J. Bourhis, I. Yakoub-Agha, J. Bay, 2020, Fundamental & clinical pharmacology.

Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience

B. Quesnel, I. Yakoub-Agha, C. Preudhomme, 2021, Blood advances.

Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

H. Lanic, P. Chevallier, M. Mohty, 2021, Blood.

Efficacy of a low dose of thalidomide in advanced multiple myeloma.

I. Yakoub-Agha, F. Bauters, X. Leleu, 2002, Blood.

High frequency of cutaneous eruptions within the first year after allogeneic hematopoietic stem cell transplantation

B. Catteau, V. Coiteux, D. Staumont-Sallé, 2023, JEADV Clinical Practice.

Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy

J. Tamburini, X. Leleu, T. Facon, 2018, Leukemia & lymphoma.